Specimen Validity Testing Market Analysis

Specimen Validity Testing Market Analysis

To get key market trends

  Download Free Sample

Based on product & services, the market is segmented as product and services. The product segment is further divided into assay kits, reagents and calibrators and disposables. The product dominated the specimen validity testing market in 2022 accounting for more than 67% of the total market share. This high market share is owing to several benefits offered by products in the early and accurate detection of specimen and samples. These products are designed to detect various forms of sample tampering or adulteration, such as dilution, substitution, or the addition of adulterants or masking agents. SVT products offer enhanced accuracy of drug testing and act as deterrent against sample manipulation or adulteration attempts.
 

Based on type, the market is segmented as laboratory testing and rapid/POC testing. The laboratory testing segment dominated the specimen validity testing market in 2022 accounting for more than 60% of the total market share. This high market share is owing to several clinical benefits offered by laboratory testing for the detection of samples and specimen. These laboratories are equipped with technological advanced devices and equipment along with highly qualified and well-trained staff. Additionally, laboratory testing provides a comprehensive analysis of biological samples to assess their integrity and authenticity. This comprehensive analysis helps in identifying any abnormalities or inconsistencies in the samples, ensuring accurate and reliable drug test results. Moreover, increased accuracy and reliability, expert interpretation, and consultation along with research and development activities is expected to augment the market growth in the estimated timeframe.
 

Based on end-use, the specimen validity testing market is segmented as drug screening laboratories, drug rehabilitation centers, pain management centers and others. The drug screening laboratories held the highest market share in 2022 and is projected to grow at 6.5% CAGR from 2023-2032. This high market share is owing to the availability of advanced detection and screening equipment and services to assist a wide customer base. Enhanced operability and accessibility to comprehensive range of tests incorporating identification of illicit drug use is expected to drive the market growth. Increasing prevalence of adulteration and alteration with urine sample for testing is expected to boost the industry growth. Thus, accessibility to better analysis coupled with highly advance and accurate testing products will boost product adoption rate in drug screening laboratories, thereby propelling the segmental revenue.
 

U.S. specimen validity testing market with a majority industry share in 2022 and is predicted to reach around USD 1.9 billion by 2032. This market share is attributable to numerous variables including the presence of key business players, an increase in the number of illicit drug use, and rising awareness regarding the specimen validity testing among others. Furthermore, the rising prevalence of prescription diversion, a growing population of drug abusers, and the implementation of stringent regulations modulating drug screening are projected to boost market expansion in the region. However, venturing government funding availability, increased initiatives to boost drug screening, and the societal effect of drug addiction are expected to accelerate product adoption rates, hence quickening corporate growth. Thus, the aforementioned factors is expected to drive the regional revenue share positively.